CATHAL GRANT: Open Payments
NPI 1255384145 · BEDFORD, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$37,539 in 232 payments from 18 companies in 2025. Trend: 2023 $87,770 · 2024 $78,155 · 2025 $37,539
Honoraria: $16,600Speaker / faculty: $9,760Food & beverage: $6,301Travel & lodging: $3,038Consulting: $1,840
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 20 | $12,454 |
| Vanda Pharmaceuticals Inc. | 24 | $10,621 |
| Tris Pharma Inc | 18 | $6,287 |
| E.R. Squibb & Sons, L.L.C. | 26 | $4,248 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 20 | $955 |
| Alkermes, Inc. | 13 | $639 |
| Teva Pharmaceuticals USA, Inc. | 19 | $462 |
| Janssen Pharmaceuticals, Inc | 18 | $394 |
| ABBVIE INC. | 23 | $365 |
| Corium, LLC | 8 | $315 |
Products named: Auvelity, FANAPT, Dyanavel XR, COBENFY, CAPLYTA, VRAYLAR, AUSTEDO XR, LYBALVI.
Industry payments across TX — which companies pay providers there.
